# US 2005/0032035 A1 · Facile diagnosis and monitoring of pneumocystis carinii infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2005/0032035 A1
- Document ID: US20050032035A1
- Status: Published application
- Kind: A1
- Application number: 10/477,980
- Filed: 2002-05-20
- Published: 2005-02-10
- Earliest claimed: 2001-05-18
- Assignees: New York University
- Inventors: Salim Merali
- Web page: https://patentgrep.com/patent/US20050032035A1

## CPC

- G01N 33/56961: {Plant cells or fungi}
- G01N 2333/37: from fungi
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Significantly low circulating, S-adenosylmethionine levels were found to be diagnostic for human Pneumocystis carinii infection, and rise in levels towards normal correlated with successful treatment. Diagnosis of P. carinii injection and monitoring of progress of treatment based thereon are described.

## Claims

### Claim 1

A method for identifying the presence of a Pneumocystis carinii infection in a human comprising the steps of
a) obtaining a blood sample from said human;
b) measuring the level of S-adenosylmethionine in said blood sample; and
c) correlating a S-adenosylmethionine level below that of an uninfected standard level as indicating the presence of a Pneumocystis carinii infection in said human.

### Claim 2 (depends on 1)

The method of claim 1 wherein said human is infected with HIV, has AIDS, has cancer, is immunosuppressed, or is otherwise susceptible to infection by Pneumocystis carinii.

### Claim 3 (depends on 2)

The method of claim 2 wherein said blood sample is plasma.

### Claim 4 (depends on 1)

The method of claim 1 wherein said level below that of an uninfected standard level is a level below two standard deviations of the mean value of asymptomatic HIV-infected individuals.

### Claim 5

A method for monitoring changes over time in the level of infection of Pneumocystis carinii in a human comprising the steps of
a) obtaining a series of sequential blood samples over time from said human;
b) measuring the level of S-adenosylmethionine in said blood samples; and
c) correlating an increase, decrease or no change in the level of S adenosylmethionine in said blood samples over time with a decrease, increase, or no change, respectively, in the level of infection of Pneumocystis carinii infection in said human.

### Claim 6 (depends on 5)

The method of claim 5 wherein said human is infected with HIV, has AIDS, has cancer, is immunosuppressed, or is otherwise susceptible to infection by Pneumocystis carinii.

### Claim 7 (depends on 5)

The method of claim 5 wherein said blood sample is plasma.

### Claim 8 (depends on 5)

The method of claim 5 wherein said human is undergoing treatment for said Pneumocystis carinii infection.
